There's A Troubling Trend Brewing In How Medical Diagnostics Startups Are Funded

Published: Jan 26, 2017

Diagnostic and medical tools companies are getting a lot of attention from tech investors lately.

Companies looking for new ways to screen the body for certain diseases — such as Genalyte, Grail and Guardant — have raised a total of $1.8 billion between 2015 and 2016, according to data from Silicon Valley Bank.

They're winning backing from classic tech investors — the same venture capitalists who backed companies like Uber. But there's a notable absence in this mix: healthcare investors.

Back to news